Aurobindo Pharma (India) Today
| AUROPHARMA | 1,224 6.70 0.55% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Aurobindo Pharma is trading at 1223.70 as of the 25th of November 2024, a 0.55 percent increase since the beginning of the trading day. The stock's open price was 1217.0. Aurobindo Pharma has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Aurobindo Pharma Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Aurobindo Pharma is entity of India. It is traded as Stock on NSE exchange. The company has 580.8 M outstanding shares. More on Aurobindo Pharma Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aurobindo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aurobindo Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aurobindo Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Aurobindo Pharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aurobindo Pharma's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| CEO Biologics | BE MBA | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal TestingCatholic | ||||
Aurobindo Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aurobindo Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAurobindo Pharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aurobindo Pharma's financial leverage. It provides some insight into what part of Aurobindo Pharma's total assets is financed by creditors.
| |||||
Aurobindo Pharma Limited (AUROPHARMA) is traded on National Stock Exchange of India in India and employs 26,015 people. Aurobindo Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 710.73 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aurobindo Pharma's market, we take the total number of its shares issued and multiply it by Aurobindo Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aurobindo Pharma operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 580.8 M outstanding shares.
Aurobindo Pharma Limited has accumulated about 27.3 B in cash with 24.65 B of positive cash flow from operations.
Check Aurobindo Pharma Probability Of Bankruptcy
Ownership AllocationAurobindo Pharma holds a total of 580.8 Million outstanding shares. Aurobindo Pharma Limited retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aurobindo Ownership Details
Aurobindo Pharma Risk Profiles
Although Aurobindo Pharma's alpha and beta are two of the key measurements used to evaluate Aurobindo Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9673 | |||
| Standard Deviation | 1.22 | |||
| Variance | 1.48 | |||
| Risk Adjusted Performance | (0.21) |
Aurobindo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aurobindo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Aurobindo Pharma Corporate Executives
Elected by the shareholders, the Aurobindo Pharma's board of directors comprises two types of representatives: Aurobindo Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurobindo. The board's role is to monitor Aurobindo Pharma's management team and ensure that shareholders' interests are well served. Aurobindo Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurobindo Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sanjeev Dani | COO Formulations | Profile |
Other Information on Investing in Aurobindo Stock
Aurobindo Pharma financial ratios help investors to determine whether Aurobindo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurobindo with respect to the benefits of owning Aurobindo Pharma security.